Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 5021 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Opus Genetics Announces Completion of Dosing in First Cohort of Phase 1/2 Trial of Gene Therapy OPGx-LCA5 in Patients with Rare Inherited Retinal Disease LCA5

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Opus Genetics, Inc.

Apollomics to Announce Full Year 2023 Financial Results and Host Conference Call on March 28, 2024

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Apollomics, Inc.

GTG Global Collaborations and Innovation Update

Read more ››

By: GlobeNewswire - 26 Mar 2024

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: LifeMD, Inc

Healis Therapeutics announces collaboration with Massachusetts General Hospital (MGH) and affiliates of Harvard Medical School to advance clinical-stage neuroscience research

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Healis Therapeutics, Inc.

Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Reviva Pharmaceuticals, Inc.

Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Orchestra BioMed, Inc.

Ayala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Ayala Pharmaceuticals, Inc.

Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Phathom Pharmaceuticals, Inc.

Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Portage Biotech, Inc.

Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Third Harmonic Bio, Inc.

Essential Pharma and AcedrA Biopharmaceuticals sign Distribution Agreement to commercialize essential medicines in the Middle East and North Africa region

Read more ››

By: GlobeNewswire - 26 Mar 2024

Surgery Partners, Inc. Announces New Senior Notes Offering

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Surgery Partners, Inc

Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Yield10 Bioscience, Inc.

Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC

Read more ››

By: GlobeNewswire - 26 Mar 2024

Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Telo Genomics Corp. | Telomir Pharmaceuticals, Inc.

Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Shockwave Medical, Inc.

Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Entera Bio Ltd.

ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: ABVC BioPharma, Inc.

Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications

Read more ››

By: GlobeNewswire - 26 Mar 2024

Related companies: Dyadic International, Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑